Abstract

Juvenile idiopathic arthritis (JIA) is not a disease, but an exclusion diagnosis that encompasses all forms of arthritis that begin before the age of 16 years, persist for more than 6 weeks, and are of unknown origin. This heterogeneous group of chronic arthritides has been classified on clinical and laboratory grounds to try to identify homogeneous, mutually exclusives categories suitable for etiopathogenic studies. During the last years evidence has accumulated suggesting that while some JIA categories identify quite definite disease entities, others represent heterogeneous conditions and in particular that a homogeneous disease entity (ANA positive, early onset oligoarthritis) is included in several different JIA categories. These and other findings suggest the need to reconsider some aspects of the current International League of Associations for Rheumatology (ILAR) JIA classification and nomenclature.

Highlights

  • Juvenile idiopathic arthritis (JIA) is not a disease, but an exclusion diagnosis that encompasses all forms of arthritis that begin before the age of 16 years, persist for more than 6 weeks, and are of unknown origin

  • During the last years evidence has accumulated suggesting that while some JIA categories identify quite definite disease entities, others represent heterogeneous conditions and in particular that a homogeneous disease entity (ANA positive, early onset oligoarthritis) is included in several different JIA categories. These and other findings suggest the need to reconsider some aspects of the current International League of Associations for Rheumatology (ILAR) JIA classification and nomenclature

  • Research which is freely available for redistribution

Read more

Summary

Introduction

From 21st European Pediatric Rheumatology (PReS) Congress Belgrade, Serbia. Juvenile idiopathic arthritis (JIA) is not a disease, but an exclusion diagnosis that encompasses all forms of arthritis that begin before the age of 16 years, persist for more than 6 weeks, and are of unknown origin.

Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.